The notices it replaced
- Reissues: PAR-24-277 Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- 2 steps back: PAR-21-322 Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- 3 steps back: PAR-18-654 Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
- 4 steps back: PAR-15-093 Basic Cancer Research in Cancer Health Disparities (R01)
Who won it before
93 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $45,402,302 in first-year total cost, median $478,030.
Most frequent study sections
- Basic Mechanisms of Cancer Health Disparities Study Section[BMCD]29
- Special Emphasis Panel[ZRG1 OBT-B (55)]23
- Special Emphasis Panel[ZRG1 OBT-Y (55)]18
- Special Emphasis Panel[ZRG1 OBT-K (55)]7
- Special Emphasis Panel[ZRG1 OBT-A (55)]4
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE5
- CASE WESTERN RESERVE UNIVERSITY5
- OHIO STATE UNIVERSITY5
- JOHNS HOPKINS UNIVERSITY4
- UNIVERSITY OF ALABAMA AT BIRMINGHAM4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | The role of adverse social-biological interactions in acute myeloid leukemia disparities1R01CA295626-01A1 · under PAR-24-277 | KHAN, IRUM | NORTHWESTERN UNIVERSITY, IL | $726,828 | BMCD |
| 2025 | The biological mechanisms of racial disparity in head and neck cancer1R01CA290401-01A1 · under PAR-21-322 | MOMEN HERAVI, FATEMEH | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $714,062 | BMCD |
| 2025 | Socioeconomic and adversity-associated immunobiologic influences on pediatric hematopoietic cell transplant outcomes1R01CA298935-01 · under PAR-21-322 | KNIGHT, JENNIFER MARYTURCOTTE, LUCIE MARIE | UNIVERSITY OF MINNESOTA, MN | $676,550 | BMCD |
| 2025 | Racial Disparities in the Mechanisms of Prostate Cancer Metastasis1R01CA295722-01 · under PAR-21-322 | MORENO, CARLOS SANCHEZ | EMORY UNIVERSITY, GA | $659,498 | BMCD |
| 2025 | Strategies to Reduce Global Health Disparities in Cervical Cancer1R01CA295696-01 · under PAR-21-322 | WU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $630,506 | BMCD |
| 2025 | Biological factors driving clinical outcomes in HPV+ oropharyngeal cancer1R37CA302718-01 · under PAR-24-277 | O'NEILL, WENDI QUINN | CASE WESTERN RESERVE UNIVERSITY, OH | $510,650 | BMCD |
| 2025 | Racial Difference in Prostate Cancer2R01CA220327-06 · under PAR-21-322 | FREEDLAND, STEPHEN JAYFREEMAN, MICHAEL R. | CEDARS-SINAI MEDICAL CENTER, CA | $460,263 | ZRG1 |
| 2025 | Molecular mediators of disparate outcomes experienced by patients of African ancestry with lung cancer1R37CA295609-01 · under PAR-21-322 | MCGRAIL, DANIEL JAMES | CLEVELAND CLINIC LERNER COM-CWRU, OH | $368,288 | BMCD |
| 2025 | Subclonal p27 Loss and Altered Tumor Immune Microenvironment as a Driver of Fatal Prostate Cancer1R01CA288760-01A1 · under PAR-21-322 | SFANOS, KAREN SANDELL | JOHNS HOPKINS UNIVERSITY, MD | $354,658 | BMCD |
| 2024 | Understanding lung cancer genomics in patients of African ancestry1R01CA286469-01A1 · under PAR-21-322 | ZHANG, JIAN | SLOAN-KETTERING INST CAN RESEARCH, NY | $730,398 | BMCD |
| 2024 | Role of disparities and aging biomarkers in accelerated cardiac aging among adolescent and young adult cancer survivors1R01CA285599-01A1 · under PAR-21-322 | HILDEBRANDT, MICHELLE A T | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $692,417 | BMCD |
| 2024 | MIZ1 Activation in Triple-negative Breast Cancer Racial Disparities1R01CA275910-01A1 · under PAR-21-322 | HUANG, ALEX YEE-CHENSCHIEMANN, WILLIAMZHU, XIAOFENG | CASE WESTERN RESERVE UNIVERSITY, OH | $617,723 | BMCD |
| 2024 | Tumor and Host Immune signatures associated with health disparities in outcomes following GD2 immunotherapy in neuroblastoma1R01CA285566-01A1 · under PAR-21-322 | DHODAPKAR, KAVITA MADHAVGOLDSMITH, KELLY C | EMORY UNIVERSITY, GA | $576,659 | BMCD |
| 2024 | Aberrant Activation of Androgen Signaling Pathways in African American Prostate Cancer1R01CA288392-01 · under PAR-21-322 | SUN, ZIJIE | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $539,633 | BMCD |
| 2024 | Genomic bases for African geo-ethnic prostate cancer health disparity1R01CA285772-01 · under PAR-21-322 | HAYES, VANESSA MARIE | UNIVERSITY OF SYDNEY | $500,626 | BMCD |
| 2024 | Unravel the novel role of S100A7 and its functional partners in Metastatic Triple Negative Breast Cancer Racial Disparity1R01CA292020-01 · under PAR-21-322 | GANJU, RAMESH K. | OHIO STATE UNIVERSITY, OH | $469,544 | BMCD |
| 2024 | Men of African Ancestry are primed for aggressive prostate cancer by high prostate androgens driven by vitamin D deficiency and megalin1R01CA290811-01 · under PAR-21-322 | NONN, LARISA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $366,242 | BMCD |
| 2024 | Understanding the biology of disparity-associated genomically stable gastric tumors1R56CA280636-01A1 · under PAR-21-322 | CARVAJAL CARMONA, LUIS GUILLERMO | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $241,500 | BMCD |
| 2023 | Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people1R01CA280639-01 · under PAR-21-322 | HUYGHE, JEROEN RPETERS, ULRIKEREDWOOD, DIANA | FRED HUTCHINSON CANCER CENTER, WA | $705,264 | BMCD |
| 2023 | Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities1R01CA285446-01 · under PAR-21-322 | BITLER, BENJAMIN GSIKORA, MATTHEW J | UNIVERSITY OF COLORADO DENVER, CO | $645,565 | BMCD |
| 2023 | Decoding tumor metabolic and immunologic interactions driving racial disparity in African American patients with bladder cancer.1R01CA282282-01 · under PAR-21-322 | GAO, JIANJUNPUTLURI, NAGIREDDYSIDDIQUI, MOHUMMAD MINHAJ | BAYLOR COLLEGE OF MEDICINE, TX | $645,401 | BMCD |
| 2023 | Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities1R01CA264525-01A1 · under PAR-21-322 | CAMP, ERNEST RAMSAYRUBINSTEIN, MARK P | OHIO STATE UNIVERSITY, OH | $642,846 | BMCD |
| 2023 | Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer1R01CA272702-01A1 · under PAR-21-322 | KIM, HARRISONSUNG, KYUNG HYUN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $577,780 | BMCD |
| 2023 | Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies1R01CA272627-01A1 · under PAR-21-322 | FURDUI, CRISTINA MARIALIU, LIANGZHANG, WEI | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $555,770 | BMCD |
| 2023 | Novel targeted therapy to reduce health disparities in pediatric leukemia1R01CA278226-01 · under PAR-21-322 | DOVAT, SINISA | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $541,022 | ZRG1 |
| 2023 | Developing Functional Human Cell Models to Study Initiation and Progression of Prostate Cancer between AA and EA men1R01CA276474-01 · under PAR-21-322 | LIU, XUEFENG | OHIO STATE UNIVERSITY, OH | $537,842 | ZRG1 |
| 2023 | Protein kinase C signaling in prostate cancer health disparities1R01CA276082-01A1 · under PAR-21-322 | KAZANIETZ, MARCELO G. | UNIVERSITY OF PENNSYLVANIA, PA | $488,027 | BMCD |
| 2023 | Role of YB1 in health disparities in triple negative breast cancer1R01CA272621-01A1 · under PAR-21-322 | SOSSEY-ALAOUI, KHALID | CASE WESTERN RESERVE UNIVERSITY, OH | $481,625 | BMCD |
| 2023 | Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma1R01CA259415-01A1 · under PAR-21-322 | TURNER, DAVID PAUL | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $481,094 | ZRG1 |
| 2023 | SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction1R01CA279170-01 · under PAR-21-322 | JIAO, KAIWANG, LIZHONG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $478,030 | BMCD |
| 2023 | SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.1R01CA276482-01A1 · under PAR-21-322 | KASTRATI, IRIDA | LOYOLA UNIVERSITY CHICAGO, IL | $465,767 | BMCD |
| 2023 | Immunogenetics of Outcomes Disparities After Allogeneic HCT2R01CA231838-07 · under PAR-21-322 | PETERSDORF, EFFIE W | FRED HUTCHINSON CANCER CENTER, WA | $442,860 | BMCD |
| 2023 | Development of blood-based methylation biomarkers for CRC risk prediction1R01CA281948-01 · under PAR-21-322 | GHOSH, JAYASHRI | TEMPLE UNIV OF THE COMMONWEALTH, PA | $390,661 | BMCD |
| 2023 | Interactions between ES-miRNAs and environmental risk factors are responsible for TNBC progression and associated racial health disparities: a novel analysis with multilevel moderation inferences1R01CA275089-01A1 · under PAR-21-322 | XI, YAGUANGYU, QINGZHAO | LSU HEALTH SCIENCES CENTER, LA | $336,263 | ZRG1 |
| 2023 | Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes1R56CA284564-01 · under PAR-21-322 | HENG, YU JING JANWULF, GERBURG M | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $299,940 | ZRG1 |
| 2022 | Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans1R01CA248923-01A1 · under PAR-18-654 | ELLISEN, LEIF WKO, NAOMI YU | MASSACHUSETTS GENERAL HOSPITAL, MA | $751,170 | ZRG1 |
| 2022 | Determining the role of germline CDH1 variants in gastric cancer outcome disparities in Hispanic/Latino patients1R37CA265967-01A1 · under PAR-21-322 | WANG, SAM C. | UT SOUTHWESTERN MEDICAL CENTER, TX | $702,611 | ZRG1 |
| 2022 | Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy1R37CA264518-01A1 · under PAR-21-322 | YAMOAH, KOSJ | H. LEE MOFFITT CANCER CTR & RES INST, FL | $684,576 | ZRG1 |
| 2022 | The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora1R01CA266040-01 · under PAR-18-654 | GARDNER, KEVIN L. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $649,645 | ZRG1 |
| 2022 | Hydrogel-based Organoids of African-American Lymphomas to Study B Cell Receptor Pathway Inhibitors1R01CA266052-01A1 · under PAR-21-322 | KOFF, JEAN LSINGH, ANKUR | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $563,593 | ZRG1 |
| 2022 | The Microbiome and Mucosal Immunity in Cervical Cancer Disparities1R01CA266050-01 · under PAR-18-654 | AVRIL, STEFANIEBURGENER, ADAM | CASE WESTERN RESERVE UNIVERSITY, OH | $559,473 | ZRG1 |
| 2022 | Understanding the role of DNA damage repair in racial disparities of triple-negative breast cancer outcomes1R01CA266041-01 · under PAR-18-654 | LIU, YINGSHAO, JIEYA | WASHINGTON UNIVERSITY, MO | $513,768 | ZRG1 |
| 2022 | Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma1R01CA265975-01A1 · under PAR-21-322 | SIDRANSKY, DAVIDTOLAND, AMANDA EWART | JOHNS HOPKINS UNIVERSITY, MD | $489,635 | ZRG1 |
| 2022 | Targeting centrosome‐mitotic kinases as a novel therapeutic approach against breast cancers in Hispanic/Latinas.1R01CA266046-01A1 · under PAR-21-322 | CRESS, WILLIAM DOUGLASSAAVEDRA, HAROLD I | PONCE SCHOOL OF MEDICINE, PR | $483,219 | ZRG1 |
| 2022 | Elevated homocysteine in African American Prostate Cancer: Association with Diet and Dietary practices, evaluating its biomarker potential, and characterizing its tumor promoting function1R01CA267090-01 · under PAR-18-654 | RUSTVELD, LUISSREEKUMAR, ARUN | BAYLOR COLLEGE OF MEDICINE, TX | $464,326 | ZRG1 |
| 2022 | Defining the Mechanism of Genome Rearrangements in Ph-Like ALL to Determine Predictive Markers in High-Risk Hispanic Populations1R37CA266042-01 · under PAR-18-654 | PANNUNZIO, NICHOLAS | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $421,097 | ZRG1 |
| 2022 | Targeted delivery of multimodal therapy for reducing prostate cancer disparity1R01CA265937-01 · under PAR-18-654 | LIU, RUNHUA RUNAZHOU, JIANGBING | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $386,974 | ZRG1 |
| 2022 | Biological Indicators of Racial Disparity in Ameloblastoma Recurrence1R01CA259307-01A1 · under PAR-18-654 | AKINTOYE, SUNDAY O | UNIVERSITY OF PENNSYLVANIA, PA | $371,719 | ZRG1 |
| 2022 | Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer1R01CA260351-01A1 · under PAR-18-654 | AGRAWAL, ANSHULILLY, MICHAEL BZI, XIAOLIN | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $370,628 | ZRG1 |
| 2021 | Variation in tumor-associated immune profiles and colorectal cancer outcomes1R01CA248931-01A1 · under PAR-18-654 | SCHMIT, STEPHANIE L. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $736,864 | ZRG1 |
| 2021 | Aggressive colorectal cancer subtypes and social disadvantage in a racially diverse cohort1R01CA259420-01 · under PAR-18-654 | PURRINGTON, KRISTEN S.ROZEK, LAURASTOFFEL, ELENA MARTINEZ | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $655,222 | ZRG1 |
| 2021 | Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer1R01CA248920-01A1 · under PAR-18-654 | CAMPBELL, JOSHUA D | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $610,293 | ZRG1 |
| 2021 | P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities1R01CA253450-01A1 · under PAR-18-654 | HOADLEY, KATHERINE A.TROESTER, MELISSA A. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $597,226 | ZRG1 |
| 2021 | Inactivation of MSH3 in Colorectal Cancer and Race1R01CA258519-01 · under PAR-18-654 | ASHKTORAB, HASSANCARETHERS, JOHN M | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $579,469 | ZRG1 |
| 2021 | Molecular Determinants of Health Disparities in Inflammatory Breast Cancer1R01CA264529-01 · under PAR-18-654 | DEVI, GAYATHRI | DUKE UNIVERSITY, NC | $518,284 | ZRG1 |
| 2021 | The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response1R01CA259396-01 · under PAR-18-654 | DAVIS, MELISSA BNEWMAN, LISA A. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $517,362 | ZRG1 |
| 2021 | Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer1R01CA264519-01 · under PAR-18-654 | COHN, BARBARA AJONES, DEAN PAUL | PUBLIC HEALTH INSTITUTE, CA | $491,293 | ZRG1 |
| 2021 | TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients1R01CA248930-01A1 · under PAR-18-654 | BHATNAGAR, SANCHITA | UNIVERSITY OF VIRGINIA, VA | $140,093 | ZRG1 |
| 2020 | The linkage between Race, Kaiso and the tumor microenvironment in breast cancer health disparities1R01CA253368-01 · under PAR-18-654 | GARDNER, KEVIN L. | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $672,210 | ZRG1 |
| 2020 | Collagen Sequence Variants in Racial Disparities of Breast Cancer1R01CA253460-01 · under PAR-18-654 | ANGEL, PEGGI M | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $552,568 | ZRG1 |
| 2020 | Epigenetic dysregulation in APC-negative colorectal cancer1R01CA242914-01A1 · under PAR-18-654 | ELLIS, NATHAN A.LLOR, XAVIER | UNIVERSITY OF ARIZONA, AZ | $541,456 | ZRG1 |
| 2020 | Discovery and therapeutic targeting of biological determinants of lung cancer health disparities1R01CA239093-01A1 · under PAR-18-654 | PINE, SHARON R. | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $416,907 | ZRG1 |
| 2020 | RACIAL DISPARITY IN THE ENERGY DEPENDENCY OF TRIPLE NEGATIVE BREAST CANCER1R01CA253445-01 · under PAR-18-654 | KAIPPARETTU, BENNY ABRAHAM | BAYLOR COLLEGE OF MEDICINE, TX | $381,240 | ZRG1 |
| 2020 | Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer1R01CA253312-01 · under PAR-18-654 | CLARKE, JEFFREY MELSONFREEDMAN, JENNIFER ANNGRAY, JHANELLE E. | DUKE UNIVERSITY, NC | $377,130 | ZRG1 |
| 2020 | Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women1R01CA242917-01A1 · under PAR-18-654 | LIU, RUNHUA RUNALIU, XIAOGUANG MARGARETWANG, LIZHONG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $339,694 | ZRG1 |
| 2019 | Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins1R01CA238087-01 · under PAR-18-654 | FIGUEIREDO, JANE C.SCHMIT, STEPHANIE L. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $727,816 | ZRG1 |
| 2019 | Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities1R01CA238061-01 · under PAR-18-654 | RAGIN, CAMILLE C.SOBOL, ROBERT W | RESEARCH INST OF FOX CHASE CAN CTR, PA | $667,865 | ZRG1 |
| 2019 | HSET as a racial disparity biomarker for TNBC patients1R01CA239120-01 · under PAR-18-654 | ANEJA, RITU | GEORGIA STATE UNIVERSITY, GA | $612,894 | ZRG1 |
| 2019 | Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer1R01CA231857-01A1 · under PAR-18-654 | GANJU, RAMESH K.RAMASWAMY, BHUVANESWARI | OHIO STATE UNIVERSITY, OH | $441,049 | ZRG1 |
| 2019 | Metabolic Rewiring Promotes AA PCa by Regulating Stromal-Epithelial Interaction1R01CA227559-01A1 · under PAR-18-654 | PALAPATTU, GANESH SSREEKUMAR, ARUN | BAYLOR COLLEGE OF MEDICINE, TX | $408,656 | ZRG1 |
| 2019 | Functional Consequences of Racially Associated Ephrin Alterations on the Prostate Tumor Microenvironment1R01CA242920-01 · under PAR-18-654 | FRANCO CORONEL, OMAR | ENDEAVOR HEALTH CLINICAL OPERATIONS, IL | $375,117 | ZRG1 |
| 2019 | Aggressive prostate cancer of African Americans is correlated with regulation of Immunoregulatory Genes in stroma1R01CA226570-01A1 · under PAR-18-654 | RAHMATPANAH, FARAH BAKHSHIAN | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $353,419 | ZRG1 |
| 2019 | Prostate Cancer Health Disparity: Role of PDEF1R01CA242839-01 · under PAR-18-654 | KOUL, HARI K | LOUISIANA STATE UNIV HSC SHREVEPORT, LA | $333,975 | ZRG1 |
| 2018 | Immunogenetics of Outcomes Disparities after Allogeneic HCT1R01CA231838-01 · under PAR-15-093 | PETERSDORF, EFFIE W | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $409,042 | ZRG1 |
| 2018 | Racial Differences in Prostate Cancer Molecular Subtyping1R01CA220327-01A1 · under PAR-15-093 | FREEDLAND, STEPHEN JAYFREEMAN, MICHAEL R | CEDARS-SINAI MEDICAL CENTER, CA | $400,313 | ZRG1 |
| 2018 | Genomics of HCC in the Hispanic population of Texas1R01CA204665-01A1 · under PAR-15-093 | BERETTA, LAURA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $390,463 | ZRG1 |
| 2018 | Colonic responses to vitamin D and aspirin in African- and European-Americans1R01CA220329-01A1 · under PAR-15-093 | KUPFER, SONIA | UNIVERSITY OF CHICAGO, IL | $370,575 | ZRG1 |
| 2018 | Impact of germline variants on racial and ethnic differences in somatic mutation frequency1R01CA215151-01A1 · under PAR-15-093 | TOLAND, AMANDA EWART | OHIO STATE UNIVERSITY, OH | $356,088 | ZRG1 |
| 2017 | Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence1R01CA209798-01A1 · under PAR-15-093 | SETIAWAN, VERONICA WENDY | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $395,145 | ZRG1 |
| 2017 | Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)1R01CA204819-01A1 · under PAR-15-093 | PAL, TUYA | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $383,100 | ZRG1 |
| 2017 | Investigating serum exosomal annexin A2 in promoting aggressive TNBC in African American women1R01CA220273-01 · under PAR-15-093 | VISHWANATHA, JAMBOOR K. | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $380,476 | ZRG1 |
| 2017 | Consequences and mechanism of aberrant splicing in African American prostate cancer disparities1R01CA204806-01A1 · under PAR-15-093 | GARCIA-BLANCO, MARIANO A.LEE, NORMAN H | GEORGE WASHINGTON UNIVERSITY, DC | $376,409 | ZRG1 |
| 2017 | Evaluation of molecular determinants of racial disparity in triple-negative breast cancer1R01CA204555-01A1 · under PAR-15-093 | SHARMA, DIPALI | JOHNS HOPKINS UNIVERSITY, MD | $373,721 | ZRG1 |
| 2017 | Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer1R01CA220297-01 · under PAR-15-093 | PUTLURI, NAGIREDDY | BAYLOR COLLEGE OF MEDICINE, TX | $370,749 | ZRG1 |
| 2017 | Race-related alternative splicing: novel targets in prostate cancer1R01CA220314-01 · under PAR-15-093 | PATIERNO, STEVEN R | DUKE UNIVERSITY, NC | $361,013 | ZRG1 |
| 2016 | Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia1R01CA209829-01 · under PAR-15-093 | DOVAT, SINISAPAYNE, KIMBERLY J | LOMA LINDA UNIVERSITY, CA | $375,047 | ZRG1 |
| 2016 | Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk1R01CA204808-01 · under PAR-15-093 | GASKINS, REXMUTLU, ECE A.RIDLON, JASON MICHAELTUSSING-HUMPHREYS, LISA | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $367,150 | ZRG1 |
| 2016 | EPHA6 as a novel candidate driver gene in colon cancer1R01CA204549-01 · under PAR-15-093 | GUDA, KISHORE | CASE WESTERN RESERVE UNIVERSITY, OH | $362,569 | ZRG1 |
| 2016 | Biological implications of breast cancer protective variants in Latin American women with high Indigenous American ancestry1R01CA204797-01 · under PAR-15-093 | FEJERMAN, LAURA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $362,569 | ZRG1 |
| 2016 | MUC13 Mucin in Colorectal Cancer Health Disparity1R01CA204552-01 · under PAR-15-093 | CHAUHAN, SUBHASH C. | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $359,410 | ZRG1 |
| 2016 | Molecular causes and mechanistic underpinning of breast cancer racial disparity1R01CA204801-01 · under PAR-15-093 | SINGH, SEEMA | UNIVERSITY OF SOUTH ALABAMA, AL | $346,556 | ZRG1 |
| 2016 | Mitochondria in Prostate Cancer Diversity1R01CA204430-01 · under PAR-15-093 | SINGH, KESHAV K | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $336,263 | ZRG1 |
| 2016 | Modulation of host intrinsic immunity to reduce prostate cancer disparity1R01CA204786-01 · under PAR-15-093 | KARAN, DEV | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $313,306 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.